Is my older cancer patient on too many medications?

[1]  M. Piccart,et al.  Drugs prescribed for patients hospitalized in a geriatric oncology unit: Potentially inappropriate medications and impact of a clinical pharmacist. , 2016, Journal of geriatric oncology.

[2]  S. Mohile,et al.  Polypharmacy and potentially inappropriate medication use in geriatric oncology. , 2016, Journal of geriatric oncology.

[3]  T. Chen,et al.  Health Care Practitioners’ Perspectives on Deprescribing Anticholinergic and Sedative Medications in Older Adults , 2016, The Annals of pharmacotherapy.

[4]  S. Shakib,et al.  Polypharmacy cut-points in older people with cancer: how many medications are too many? , 2016, Supportive Care in Cancer.

[5]  J. Bell,et al.  What factors are important for deprescribing in Australian long-term care facilities? Perspectives of residents and health professionals , 2016, BMJ Open.

[6]  Mary Jordan Samuel.  American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults , 2015, Journal of the American Geriatrics Society.

[7]  L. Balardy,et al.  Polypharmacy and Potentially Inappropriate Medication Use Among Senior Adults With Cancer: What Is the Best Approach? , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  M. Bouvy,et al.  Majority of drug-related problems identified during medication review are not associated with STOPP/START criteria , 2015, European Journal of Clinical Pharmacology.

[9]  Amy P Abernethy,et al.  Polypharmacy in patients with advanced cancer and the role of medication discontinuation. , 2015, The Lancet. Oncology.

[10]  L. Chew,et al.  Drug-related problems in elderly patients with cancer receiving outpatient chemotherapy. , 2015, Journal of geriatric oncology.

[11]  A. Abernethy,et al.  Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness: a randomized clinical trial. , 2015, JAMA internal medicine.

[12]  I. Scott,et al.  Reducing inappropriate polypharmacy: the process of deprescribing. , 2015, JAMA internal medicine.

[13]  Emily R. Hajjar,et al.  Evaluation of a pharmacist-led medication assessment used to identify prevalence of and associations with polypharmacy and potentially inappropriate medication use among ambulatory senior adults with cancer. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  H. Wildiers,et al.  Fall predictors in older cancer patients: a multicenter prospective study , 2014, BMC Geriatrics.

[15]  I. Scott,et al.  Prescriber barriers and enablers to minimising potentially inappropriate medications in adults: a systematic review and thematic synthesis , 2014, BMJ Open.

[16]  N. Kerse,et al.  Interventions to improve the appropriate use of polypharmacy for older people. , 2014, The Cochrane database of systematic reviews.

[17]  J. Lees,et al.  Potentially inappropriate medication use in older people with cancer: prevalence and correlates. , 2014, Journal of geriatric oncology.

[18]  M. Wiese,et al.  The benefits and harms of deprescribing , 2014, The Medical journal of Australia.

[19]  M. Wiese,et al.  Review of deprescribing processes and development of an evidence‐based, patient‐centred deprescribing process , 2014, British journal of clinical pharmacology.

[20]  J. Tooze,et al.  The prognostic importance of polypharmacy in older adults treated for acute myelogenous leukemia (AML). , 2014, Leukemia research.

[21]  M. Popa,et al.  Potential drug interactions and chemotoxicity in older patients with cancer receiving chemotherapy. , 2014, Journal of geriatric oncology.

[22]  J. Bell,et al.  Prevalence and factors associated with polypharmacy in older people with cancer , 2014, Supportive Care in Cancer.

[23]  A. Wymenga,et al.  Baseline comprehensive geriatric assessment is associated with toxicity and survival in elderly metastatic breast cancer patients receiving single-agent chemotherapy: results from the OMEGA study of the Dutch breast cancer trialists' group. , 2014, Breast.

[24]  L. Huiart,et al.  Complementary or Alternative Medicine as Possible Determinant of Decreased Persistence to Aromatase Inhibitor Therapy among Older Women with Non-Metastatic Breast Cancer , 2013, PloS one.

[25]  Li-Chia Chen,et al.  Disease acceptance and adherence to imatinib in Taiwanese chronic myeloid leukaemia outpatients , 2013, International Journal of Clinical Pharmacy.

[26]  M. Steinman,et al.  Polypharmacy and the management of the older cancer patient. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[27]  M. Wiese,et al.  Patient Barriers to and Enablers of Deprescribing: a Systematic Review , 2013, Drugs & Aging.

[28]  K. Yamashita,et al.  Concomitant polypharmacy is associated with irinotecan-related adverse drug reactions in patients with cancer , 2013, International Journal of Clinical Oncology.

[29]  C. Tannenbaum,et al.  Prevalence and Risk of Potential Cytochrome P450–Mediated Drug-Drug Interactions in Older Hospitalized Patients with Polypharmacy , 2013, The Annals of pharmacotherapy.

[30]  D. Cope.  Polypharmacy in Older Adults: The Role of the Advanced Practitioner in Oncology , 2013, Journal of the advanced practitioner in oncology.

[31]  S. Hartikainen,et al.  Analgesic Use and Frailty among Community-Dwelling Older People , 2013, Drugs & Aging.

[32]  D. L. Le Couteur,et al.  Thinking through the medication list - appropriate prescribing and deprescribing in robust and frail older patients. , 2012, Australian family physician.

[33]  A. Engeland,et al.  Prescribing quality for older people in Norwegian nursing homes and home nursing services using multidose dispensed drugs , 2012, Pharmacoepidemiology and drug safety.

[34]  S. Wyke,et al.  Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study , 2012, The Lancet.

[35]  Siran Koroukian,et al.  Patient Characteristics Associated with Polypharmacy and Inappropriate Prescribing of Medications among Older Adults with Cancer. , 2012, Journal of geriatric oncology.

[36]  S. Pearson,et al.  Discontinuation of statin therapy in older people: does a cancer diagnosis make a difference? An observational cohort study using data linkage , 2012, BMJ Open.

[37]  H. Cohen,et al.  Senior adult oncology clinical practice guidelines in oncology. , 2012, Journal of the National Comprehensive Cancer Network : JNCCN.

[38]  B. Buurman,et al.  The value of a comprehensive geriatric assessment for patient care in acutely hospitalized older patients with cancer. , 2011, The oncologist.

[39]  Göran Petersson,et al.  Increasing polypharmacy - an individual-based study of the Swedish population 2005-2008 , 2010, BMC clinical pharmacology.

[40]  D. Garfinkel,et al.  Feasibility study of a systematic approach for discontinuation of multiple medications in older adults: addressing polypharmacy. , 2010, Archives of internal medicine.

[41]  C. Gross,et al.  Polypharmacy in older adults with cancer. , 2010, The oncologist.

[42]  A. Ring,et al.  The treatment of co-morbidities in older patients with metastatic cancer , 2010, Supportive Care in Cancer.

[43]  Kellie L. Flood,et al.  Polypharmacy in hospitalized older adult cancer patients: experience from a prospective, observational study of an oncology-acute care for elders unit. , 2009, The American journal of geriatric pharmacotherapy.

[44]  R. Riechelmann,et al.  Futile medication use in terminally ill cancer patients , 2009, Supportive Care in Cancer.

[45]  S. Pauker,et al.  Discontinuing Medications: A Novel Approach for Revising the Prescribing Stage of the Medication‐Use Process , 2008, Journal of the American Geriatrics Society.

[46]  Reamer L. Bushardt,et al.  Polypharmacy: Misleading, but manageable , 2008, Clinical interventions in aging.

[47]  P. Gallagher,et al.  STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. , 2008, International journal of clinical pharmacology and therapeutics.

[48]  D. Garfinkel,et al.  The war against polypharmacy: a new cost-effective geriatric-palliative approach for improving drug therapy in disabled elderly people. , 2007, The Israel Medical Association journal : IMAJ.

[49]  G. Vlastos,et al.  Older female cancer patients: importance, causes, and consequences of undertreatment. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[50]  Lisa Wang,et al.  Potential drug interactions and duplicate prescriptions among cancer patients. , 2007, Journal of the National Cancer Institute.

[51]  E. Kuipers,et al.  Systematic review: rebound acid hypersecretion after therapy with proton pump inhibitors , 2006, Alimentary pharmacology & therapeutics.

[52]  A. Wu,et al.  Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. , 2005, JAMA.

[53]  R. Riechelmann,et al.  Potential for drug interactions in hospitalized cancer patients , 2005, Cancer Chemotherapy and Pharmacology.

[54]  A. Abernethy,et al.  Managing comorbidities in patients at the end of life , 2004, BMJ : British Medical Journal.

[55]  L. Balducci.  Management of cancer pain in geriatric patients. , 2003, The journal of supportive oncology.

[56]  J. Ebbesen,et al.  Fatal adverse drug events: the paradox of drug treatment , 2001, Journal of internal medicine.

[57]  L. Fried,et al.  Frailty in older adults: evidence for a phenotype. , 2001, The journals of gerontology. Series A, Biological sciences and medical sciences.

[58]  M. Extermann,et al.  Management of cancer in the older person: a practical approach. , 2000, The oncologist.

[59]  G P Samsa,et al.  Adverse events after discontinuing medications in elderly outpatients. , 1997, Archives of internal medicine.

[60]  S. Wallerstedt,et al.  PHARMACOEPIDEMIOLOGYAND PRESCRIPTION Number of drugs in the medication list as an indicator of prescribing quality: a validation study of polypharmacy indicators in older hip fracture patients , 2015 .

[61]  J. Hallas,et al.  Polypharmacy and drug use in elderly Danish cancer patients during 1996 to 2006 , 2012 .

[62]  K. Johnell,et al.  The Relationship between Number of Drugs and Potential Drug-Drug Interactions in the Elderly , 2007, Drug safety.